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Abstract. Recently, we have reported the presence of fungal infections in patients with Alzheimer’s disease (AD). Accordingly,
fungal proteins and DNA were found in brain samples, demonstrating the existence of infection in the central nervous system.
In the present work, we raised antibodies to specific fungal species and performed immunohistochemistry to directly visualize
fungal components inside neurons from AD patients. Mice infected with Candida glabrata were initially used to assess whether
yeast can be internalized in mammalian tissues. Using polyclonal rabbit antibodies against C. glabrata, rounded immunopositive
cells could be detected in the cytoplasm of cells from liver, spleen, and brain samples in infected, but not uninfected, mice.
Immunohistochemical analyses of tissue from the frontal cortex of AD patients revealed the presence of fungal material in a
small percentage (∼10%) of cells, suggesting the presence of infection. Importantly, this immunopositive material was absent
in control samples. Confocal microscopy indicated that this fungal material had an intracellular localization. The specific
morphology of this material varied between patients; in some instances, disseminated material was localized to the cytoplasm,
whereas small punctate bodies were detected in other patients. Interestingly, fungal material could be revealed using different
anti-fungal antibodies, suggesting multiple infections. In summary, fungal infection can only be observed using specific anti-
fungal antibodies and only a small percentage of cells contain fungi. Our findings provide an explanation for the hitherto elusive
detection of fungi in AD brains, and are consistent with the idea that fungal cells are internalized inside neurons.
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INTRODUCTION
A major challenge in medicine at present is
uncovering the precise etiology of a number of neu-
rodegenerative diseases. These types of disorders are
of paramount importance from a social and economic
viewpoint. Alzheimer’s disease (AD) is one of the
most threatening neurodegenerative diseases, partic-
ularly for the elderly [1]. Improvement in the current
treatment of AD very much depends on the knowledge
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of its etiology. The most accepted theory for the ori-
gin of AD is the “amyloid cascade hypothesis” [2, 3].
Extracellular deposits of amyloid- peptide (A) con-
stitute a cytological hallmark in AD brains, and the
amyloid cascade hypothesis proposes that the initial
symptoms of the disease can be explained by the depo-
sition of A that is produced by an imbalance between
the production and clearance of this peptide. However,
this concept does not explain some clinical symptoms
of AD [4]. We recently reported the existence of dis-
seminated mycoses in AD patients [5, 6]. Accordingly,
several fungal macromolecules including fungal pro-
teins and polysaccharides ((1,3)--glucan) could be
detected in peripheral blood serum from patients, and
fungal proteins were found in brain tissue [5]. The
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species of fungi present in these samples were iden-
tified by sequence analysis from PCR-amplified DNA.
The conclusion from these studies is that mixed fun-
gal infections may be present in the central nervous
system (CNS) of AD patients, providing a possible
explanation for the variability in the evolution and
severity of clinical symptoms observed. In support of
this hypothesis, the A peptide exhibits potent antimi-
crobial activity against Candida albicans and some
bacteria [7], pointing to the possibility that secretion
of A is triggered by microbial infection as part of
the innate immune response [8]. Indeed, exposure of
cultured neuronal cells to spirochetes, or to bacterial
lipopolysaccharide, induces deformation of A pep-
tide and hyperphosphorylation of tau proteins [9–11].
Notably, the antimicrobial peptide -defensin-1 is
upregulated in brain from AD patients [12]. Further-
more, amyloid can be formed from fungal adhesion
proteins, as deposits of amyloid plaques on the sur-
face of fungal cells [13, 14]. These amyloid deposits
lead to the development of fibrils containing glucans
and other polysaccharides, which in turn may interact
with human serum amyloid P component that coats
fungal cells and hyphae, participating in the evasion of
the immune system [15, 16]. The existence of chitin-
like structures in brain from AD patients has been
demonstrated [17], together with a significant increase
in chitinase (chitotriosidase) activity in cerebrospinal
fluid (CSF) [18]. Intriguingly, the presence of fun-
gal infection was detected in some patients several
years after diagnosis of AD, and antifungal treatment
reversed the clinical symptoms [19, 20]. In the present
work, we provide further evidence for CNS infection
with fungi. Immunohistochemical analyses reveal that
a few cells in brains from AD patients contain cytoplas-
mic material that immunoreacts with antibodies raised
against some yeast cells.
MATERIALS AND METHODS
Brain samples from AD patients
The samples analyzed in this study correspond to
tissue sections obtained from brain donors diagnosed
of AD. Information on these patients is listed in Sup-
plementary Table 1. Morphological data analyzed in
this work were assessed by an observer blinded to
the diagnosis. The Ethics Committee of Universidad
Auto´noma de Madrid approved the study. The trans-
fer of samples was carried out according to national
regulations concerning research on human biologi-
cal samples. For all cases, written informed consent
is available. All ethico-legal documents of the brain
bank, including written informed consent, have been
approved by an ethics committee external to the bank.
The brain bank that supplied the brain tissue samples
is Banco de Tejidos CIEN, belonging to Instituto de
Salud Carlos III, the Spanish National Health Insti-
tute (http://bt.fundacioncien.es/). General procedures
of the brain bank have been published in: Alzheimer
Center Reina Sofia Foundation: fighting the disease
and providing overall solutions. Briefly, a rapid neu-
ropathological autopsy was performed shortly after
communication of the donor’s decease by their proxies.
Immediately after brain extraction, two symmetri-
cal brain halves were obtained in fresh through a
mid-sagital cut. The right half was frozen in −50◦C
isopentane after serial cutting of the brain hemisphere,
the cerebellar hemisphere and the brainstem. The left
half was fixed in 4% phosphate-buffered formaldehyde
during 3 weeks, and thereafter it was cut and sampled.
A total 25 tissue blocks were obtained and embedded
in paraffin.
Mouse infection with C. glabrata
To analyze the appearance of C. glabrata in different
mouse tissues, nude mice were employed to facilitate
yeast infection of different organs. C. glabrata was
employed for several reasons: this yeast gives rise to
intracellular infection of culture cells [23] and also we
have obtained rabbit antibodies against this yeast. Four
nude mice were infected by intravenous injection of
5.8 × 106 colony forming units (cfu) of C. glabrata
in 0.3 ml of phosphate-buffered saline (PBS). Control
mice remained uninfected. Mice were sacrificed after
90 days, and spleen, brain, and liver were extracted
for analysis. This experiment was repeated twice. The
organs were fixed and prepared for immunohistochem-
ical analyses as detailed below.
Fungal growth
Fungi (C. glabrata, C. albicans, and C. parapsilo-
sis) were grown in YEP medium (1% yeast extract, 2%
peptone, 2% glucose) at 30◦C. Syncephalastrum race-
mosum and Penicillium notatum were purchased from
Allergon AB (Sweden).
Production of polyclonal antibodies
Rabbit antisera against C. albicans, C. parapsilo-
sis, C. glabrata, P. notatum, and S. racemosum were
obtained by inoculation of 1 or 2 mg of dried fungi
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(after autoclaving and lyophilization) in 0.5 ml PBS.
Each inoculum had been previously mixed with an
equal volume of Freund’s adjuvant. Rabbits were inoc-
ulated up to four times every three weeks and the
antibody titer and specificity of the sera were tested
by immunohistochemistry and immunoblotting.
Histological analysis
Paraffin sections (5m) were fixed in 10% buffered
formalin for 24 h and then embedded in paraffin follow-
ing standard protocols. Sections (4m) were stained
with hematoxylin-eosin, washed in running tap water
for 5 min, dehydrated in a series of ethanol/water,
cleared in xylene and mounted in DPX (Merck).
To carry out the immunohistochemical analysis,
paraffin was removed and the tissues were rehydrated,
boiled for 2 min in citrate buffer, and washed for 10 min
in ammonium chloride (50 mM) at room temperature.
Subsequently, tissue sections were washed with PBS
tween and incubated for 20 min with PBS/BSA 2%.
Sections were then incubated overnight at 4◦C with
the various antibodies at a 1 : 500 dilution, washed
with PBS and incubated with the corresponding sec-
ondary antibody (all from Invitrogen). As indicated
in each experiment, donkey anti-rabbit IgG secondary
antibody conjugated with Alexa 647 (Invitrogen) was
added at a 1 : 200 dilution. Where indicated, brain sec-
tions were incubated with anti-tau antibody at a 1 : 100
dilution (T100, Fisher) followed by incubation with
secondary antibody donkey anti-mouse IgG bound to
Alexa 594 at a 1 : 500 dilution. In other experiments,
sections were incubated with anti-tubulin antibody at a
1 : 1000 dilution (Sigma) followed by incubation with
secondary antibody donkey anti-mouse IgG conju-
gated to Alexa 488 at a dilution 1 : 200. Finally, sections
were observed under a Zeiss Axiovert 200 microscope.
Confocal microscopy was carried out using a con-
focal laser scanning microscope LSM710 coupled to
vertical microscopy AxioImager.M2 (Zeiss). The spec-
tral system employed was Quasar + 2 PMTs. Zeiss
ZEN 2010 Program.
RESULTS
Immunohistochemical analysis of tissues from
mice infected with C. glabrata
We have previously shown that yeast cells, such as
C. famata, can attach and enter cultured human cells
[21]. These observations are consistent with findings
from other laboratories reporting intracellular infec-
tion of mammalian cells by several fungi [22–25].
Initially, we wished to demonstrate that yeast can also
be internalized in different tissues in mice. For this
reason, we employed nude mice in order to allow a
better infection. Thus, nude mice were injected intra-
venously with live C. glabrata. Three months after
infection, mice were sacrificed and tissue sections
were obtained from various organs and immunos-
tained with anti-C.glabrata antibodies. As control, we
analyzed uninfected mice and mouse tissue treated
with pre-immune serum. Immunohistochemical anal-
ysis revealed the localization of fungal cells in spleen,
liver and brain samples, appearing as rounded bodies
possibly in the cell cytoplasm (Fig. 1). Importantly,
no immune-positive staining was detected in tissues
from uninfected mice, demonstrating that the antibod-
ies employed do not cross-react with mouse cellular
components. Also, no reactivity was found with pre-
immune serum. These results illustrate that yeast cells
can be detected in mouse tissues and these rounded
bodies have a size of about 1 micron.
In order to determine if these rounded bodies that
immunoreact with the anti-C. glabrata antibodies are
intracellular, confocal microscopy was carried out.
Brain sections from both uninfected or C. glabrata-
infected mice were examined. Figure 2 clearly shows
that these yeast rounded bodies are intracellular and
localize in the cytoplasm, we propose to refer to them
as “intramycosomes”. Therefore, the nude mice sys-
tem serves to provide an idea about the appearance of
intracellular yeast cells in brain tissue.
Immunohistochemistry of AD brain samples with
anti-C. glabrata antibodies
The main goal of this study was to assess the poten-
tial presence of fungal components in brain tissue from
AD patients using anti-C. glabrata antibodies. It must
be considered that fungal antibodies were obtained
using whole yeast cells comprising many proteins and
also polysaccharides, and thus cross-reactivity may
occur with related fungal antigens. However, as demon-
strated, they do not recognize any component in mouse
tissue. Serial sections of the frontal cortex of a human
control or an AD brain (AD 1) were stained with
hematoxylin-eosin to visualize the typical presentation
of neurons (Fig. 3A). Whereas typical frontal cortex
neurons were observed in control tissue, frontal cortex
sections from AD brains contained less neurons, with
apparent gliosis. Additionally, immunohistochemical
analysis using antibodies that immunoreact with hyper-
phosphorylated tau protein revealed the formation
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Fig. 1. Immunohistochemical analysis of mouse tissues using anti-C. glabrata antibodies. Immunofluorescence of C. glabrata grown in YEP
medium using rabbit polyclonal antibodies raised against C. glabrata (upper panel). Four nude mice were infected with 5.8×106 cfu C. glabrata
by i.v. injection. 90 days later, mice were sacrificed and liver, spleen, and brain were collected. This experiment has been repeated twice with four
animals each time. Uninfected animals served as a control. Sections were obtained from fixed tissue and immunohistochemistry was performed.
Sections were incubated with anti-C. glabrata antibodies (1 : 500 dilution) or with preimmune serum as indicated in the Figure, followed by
incubation with secondary antibody donkey anti-rabbit IgG conjugated to Alexa 647 (1 : 500). Scale bar: 20m. At least, 15 different fields
were examined in each sample (400x magnification).
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Fig. 2. Confocal microscopy of brain sections from C. glabrata-infected nude mice. Four nude mice were infected with 5.8×106 cfu C. glabrata
by i.v. injection. 90 days later, mice were sacrificed and brains were collected. This experiment has been repeated twice with four animals
each time. Uninfected animals served as a control. Sections were obtained from fixed tissue and immunohistochemistry was performed. Brains
were incubated with anti-C. glabrata antibodies (1 : 500 dilution) or with preimmune serum (1 : 500) as indicated in the Figure, followed by
incubation with secondary antibody donkey anti-rabbit IgG conjugated to Alexa 647 (1 : 500). Afterwards, sections were incubated with Dapi
1g/ml. The different panels in the figure are indicated. Merge is the result of mixed red and blue panels. Brains were observed under a Confocal
laser scanning microscope LSM710 coupled to vertical microscopy AxioImager.M2 (Zeiss). Scale bar: 30m. At least, 15 different fields were
examined in each sample (400x magnification).
of tangles in AD tissue sections, but not in control
brain (Fig. 3A). Notably, double immunofluorescence
staining of AD brain sections using anti-tubulin and
anti-C. glabrata antibodies demonstrated the presence
of microtubules in the cytoplasm (green), and also
small punctate bodies (red) that immunoreacted with
the antifungal antibodies and seemed also to local-
ize in the cytoplasm (Fig. 3B). This morphology was
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Fig. 3. Immunohistochemical analysis of control and AD brain sections. A) Hematoxylin-eosin staining of brain sections (frontal cortex) from
control patient 1 and AD patient 1 (AD1) observed under a Zeiss Axiovert 200 microscope (200x magnification) (upper panels). Immuno-
histochemistry of hyperphosphorylated tau protein using a specific anti-tau antibody (1 : 100 dilution), followed by incubation with secondary
antibody donkey anti-mouse IgG conjugated to Alexa 594 (1 : 500) (lower panels). B) Immunohistochemistry using anti-tubulin and anti-C.
glabrata antibodies in control 1 and AD1 brain sections. Sections were incubated with anti-tubulin (1 : 1000 dilution) and anti C.glabrata (1 : 500)
antibodies, followed by incubation with secondary antibody donkey anti-mouse IgG conjugated to Alexa 488 (green) (1 : 200) and incubation
with donkey anti-rabbit IgG conjugated to Alexa 647 (red) (1 : 500 dilution), respectively. The different panels in the figure are indicated. Merge
is the result of mixed green and red panels. Scale bar: 20m. At least, 15 different fields were examined (630x magnification). C) Immunohis-
tochemical analysis of brain sections from different AD patients. Sections were incubated with anti-C. glabrata antibodies (1 : 500 dilution) and
anti-tubulin (1 : 1000), followed by incubation with secondary antibody donkey anti-rabbit IgG conjugated to Alexa 647 (red) (1 : 500) and with
secondary antibody donkey anti-mouse IgG conjugated to Alexa 488 (green) (1 : 200), respectively. The different panels of the figure from left
to right are: phase contrast, tubulin, anti-C.glabrata and merge. Merge is the combination of green (tubulin) and red (anti-C. glabrata) panels.
Scale bar: 20m. At least, 15 different fields were examined (630x magnification).
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not observed in control brain sections, demonstrating
that anti-C. glabrata antibodies do not recognize any
component in human brain. Importantly, the secondary
anti-rabbit antibodies employed were conjugated to
Alexa 647, avoiding the autofluorescence of human
brain tissue. Significantly, the immunopositive punc-
tate material was probably intracellular and seemed to
be present in the cytoplasm of neurons (see below).
Indeed, the morphology observed was reminiscent of
the staining produced after infection of mice with C.
glabrata (Fig. 1). Crucially, the immunopositive mate-
rial was not present in all neurons; approximately 10%
ofneuronsexhibited thispunctatemorphology.Ofnote,
the existence of this intracellular material was only
apparent using specific antibodies, and may explain
why it has not previously been reported, although some
similarities with chitin staining are clear [17].
The possibility that fungal material co-localizes with
amyloid plaques remains to be investigated. However,
it should be taken into consideration that these plaques
represent a host response and the secreted peptides may
accumulate in regions distant to the infection sites.
Analysis of different AD patients employing
anti-C. glabrata antibodies
We next extended this analysis and tested frontal cor-
tex tissue from an additional three patients (AD 2–4)
using double immunofluorescence staining to visual-
ize tubulin and fungal material. The results presented
in Fig. 3C clearly demonstrate that immunopositive
material could be observed in other AD patients. More-
over, the particular morphology found with anti-C.
glabrata antibodies varied from patient to patient.
Thus, intracellular bodies of about 1 micron were
evident, but the number and intracellular distribu-
tion of these immunoreactive bodies differed. In one
patient (AD 4), a typical punctate cytoplasmic material
chiefly located surrounding the nucleus was observed,
while staining distributed in the cytoplasm was visu-
alized in a second patient (AD 2). In another patient
(AD 3), the number of cytoplasmic bodies was lower.
In summary, while the morphology observed with
the antifungal antibodies differs between patients, in
all samples tested, only a small percentage of cells
are positive for the presence of these fungal-related
components. Importantly, no immunopositive bodies
were found in control samples, indicating that the
anti-C. glabrata antibodies did not recognize neuron
components.
In order to assess if this fungal-related material
observed in brain tissue from AD patients was intra-
cellular, confocal microscopy was carried out. Figure 4
shows the intracellular bodies and the cytoplasmic
distribution in patient AD 1. In conclusion, the fungal-
related material resembles that observed in brain mice
and it is clearly intracellular. This may be another
reason to account for the elusiveness to detect this
infection.
Comparative immunohistochemical analysis using
different antifungal antibodies
Our previous work suggested that AD patients may
present different fungal infection, and also that mixed
fungal infections can occur in the same patient [5]. We
therefore assessed whether frontal cortex tissue from
AD brains could immunoreact with antibodies raised
against other fungal species. To this end, we obtained
rabbit polyclonal antibodies against Penicillium nota-
tum, Syncephalastrum racemosum, C. albicans, and
C. parapsilosis. Clearly, these antibodies can recog-
nize different antigens, but it is also possible that the
recognition of some fungal antigens may be com-
mon to all fungi. As before, no immunoreactivity was
observed in control brain sections (not shown), indi-
cating that potential antigens for the rabbit polyclonal
antibodies were absent in neural cells. Interestingly,
the anti-P. notatum antibody detected small intracellu-
lar bodies localized most probably to the cytoplasm
surrounding the nucleus in a few neurons (Fig. 5).
This punctate morphology did not appear in neighbor-
ing neurons, further supporting the notion that only
a few cells are infected. Additionally, punctate bod-
ies immunostained with the anti-P. notatum antibody
were detected in a blood vessel (Fig. 5), suggesting
that capillaries may also be infected by fungi. Indeed,
it is well established that fungi can directly infect
blood vessels, provoking vasculitis in the CNS [26,
27]. Neurovascular inflammation present in the vast
majority of AD patients [28, 29] could conceivably
be explained by direct fungal infection of blood ves-
sels. Staining with antibodies to S. racemosum and
C. albicans also revealed a number of punctate bod-
ies around and inside neurons (Fig. 5). Again, many
neurons were immunonegative, and thus served as an
internal control for the specificity of the antibody. As
indicated, it is plausible that the different antibody
preparations employed immunoreact with different
fungal cells or components. If mixed fungal infection
exists in a single patient, perhaps the different anti-
bodies detect distinct infected neurons. Alternatively,
if there is cross reactivity between these antibodies
they could detect common antigens. Nevertheless, the
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Fig. 4. Confocal microscopy of brain sections from control and AD1 patient. Brain sections (frontal cortex) from control 2 and AD patient 1
(AD1) observed under a Confocal laser scanning microscope LSM710 coupled to vertical microscopy AxioImager.M2 (Zeiss). Sections were
obtained from fixed tissue and immunohistochemistry was performed as described in the legend of Fig. 3. Sections were incubated with anti-C.
glabrata antibodies (1 : 500 dilution) or with preimmune serum (1 : 500) as indicated in the Figure, followed by incubation with secondary
antibody donkey anti-rabbit IgG conjugated to Alexa 647 (1 : 500). Afterwards, sections were incubated with Dapi 1g/ml. The different panels
in the figure are indicated. Merge is the result of mixed red and blue panels. Scale bar: 30m. At least, 15 different fields were examined in
each sample (400x magnification).
use of different anti-fungal antibodies serves to high-
light the presence of punctate material that exists in
some neurons. Thus, these data reinforce the notion
that the observed bodies are of fungal origin. Of
note, an antibody raised against C. parapsilosis failed
to immunoreact with AD samples, and the pattern
observed was similar to that of control samples. This
negative result is consistent with the idea that the anti-
body preparations employed recognize specific fungal
antigens.
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Phase contrast Inmmunoflourescence
P. notatum
P. notatum
C. albicans
C. parapsilopsis
S. racemosum
Fig. 5. Immunohistochemical analysis of brain sections from AD patient 2 (AD2) using rabbit polyclonal antibodies raised against different
fungi (P.notatum, C.albicans, S.racemosum, and C.parapsilosis). Sections were incubated with anti-fungal antibodies (1 : 500), followed by
incubation with secondary antibody donkey anti-rabbit IgG conjugated to Alexa 647 (1 : 500 dilution). The different panels of the figure from
left to right are: Phase contrast and red (anti-fungal antibody). Scale bar: 20m. At least, 15 different fields were examined (630x magnification).
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DISCUSSION
The possibility that AD is caused by microbial infec-
tion has been proposed by a number of investigators.
Both viruses and bacteria have been alleged to be
the causal agents of this disease [30, 31], including
herpes viruses [32]. Also, several bacteria, including
Chlamydophila pneumonia and spirochetes, have been
detected in AD patients [33–35]. Recently, we have
suggested that fungal infections may represent a risk
factor, or possibly the cause of AD [5, 6]. We pro-
vided evidence that fungal macromolecules are present
in peripheral blood from the vast majority of AD
patients examined. In addition, fungal proteins were
identified in CNS tissue from AD patients after poly-
acrylamide gel electrophoresis and mass spectrometry
analysis, and fungal DNA was detected by PCR. These
observations are consistent with disseminated fungal
infections affecting AD patients. Our present results
using specific antibodies to detect fungal material
inside neurons add further support to the concept that
AD patients are infected with fungi. Consistent with
this idea, chitin-like material has been detected in
brain tissue from AD patients [17]. It is conceivable
that the calcofluor staining method employed to detect
chitin identified intracellular fungal cells, although this
possibility was not considered. It is noteworthy that
antifungal treatment reversed the clinical symptoms of
some patients diagnosed with AD [19, 20]. Addition-
ally, the cytokine and inflammatory molecule profile
found in AD patients is reminiscent to that elicited by
fungal infection [36, 37].
Several possibilities could explain the detection of
fungal macromolecules in AD brains. One possibility
is that, for reasons yet to be determined, AD patients
are prone to fungal infection. This may ostensibly
be due to various reasons, e.g., a dysfunction of the
immune system, genetic background, age, and way
of life, etc. Another possibility is that contamination
can occur when obtaining and processing brain tissue.
However, no fungal macromolecules were found in
control brain, supporting the view that these operations
do not necessarily lead to fungal contamination. More-
over, the detection of fungal proteins by proteomic
analyses is difficult to explain only if contamination
exists. Nevertheless, our finding that only a small per-
centage of neurons immunoreact with antibodies raised
against fungi rule out the possibility that this is due
to contamination, particularly if it is considered that
the immunoreactive material is located inside neurons.
It can also be thought that the fungal-related material
described in this work corresponds to fungal remnants
of a fungal infection that occurred before AD and that
this material is unrelated to the pathology of the dis-
ease. However, fungal material diminishes in culture
cells infected with yeast a few days after entry [21].
Finally, the most likely possibility in our opinion could
be that AD patients are indeed infected by fungi, which
cause this chronic and progressive disease. To the best
of our knowledge, there are no reasons to discard this
idea. Moreover, a number of well-established obser-
vations in AD are consistent with the hypothesis that
fungi are the etiological agents of AD. As indicated
previously, AD is a chronic and progressive disease, as
occurs in fungal infection if untreated. Also, the sever-
ity and evolution of clinical symptoms can vary widely
between different patients, which could be explained
by different fungal species or different combinations
of mixed fungal infections. Additionally, the vascular
pathology observed in AD patients could be caused
by direct infection of blood vessels by fungi. Strik-
ingly, immunoreactive material can also be observed
around blood vessels, which could explain the vas-
cular modifications observed in the majority of AD
patients. Therefore, it is plausible that the chitin-like
material described previously in close connection to
blood vessels in AD [17] is due to fungal infection. It
is well accepted that neuroinflammation occurs in AD,
with infiltrates of T-lymphocytes and monocytes that
are responsible, together with microglia cells, for the
increase in a number of cytokines in the CNS [38–40].
Systemic inflammation also exists in AD patients, with
the production of a number of interleukins and other
cytokines that are increased in peripheral blood many
years before the initiation of cognitive decline [41, 42].
In this context, increased levels of IL-1, IFN-, TNF-
 and reactive C protein have been described in fungal
infections and in AD peripheral blood and CNS after
microglia activation [36, 37, 40, 43–45]. Notably, IL-
17A, which plays a pivotal role in the immune response
against fungal infections [46–48], is also increased
in AD T-lymphocytes [49, 50]. This increase in the
immune response supports the possibility that chronic
fungal infections are present in AD patients [37]. The
genetic susceptibility of individuals to different fungal
infections is also in accord with the existence of famil-
ial susceptibility to AD in a small percentage of the
population [51].
The fact that yeast can enter mammalian cells giving
rise to a rounded morphology, together with their small
size (which can be 1 micron or less), makes the detec-
tion of fungi challenging. Also, the existence of these
intracellular forms of fungal cells cannot be easily
demonstrated unless specific reagents are employed.
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This difficulty is greater if only a small percentage
of neurons and other brain cells are infected. Collec-
tively, these concepts may provide an explanation for
the hitherto elusive detection of fungal infections in
neurodegenerative diseases, such as multiple sclerosis
or AD. There is a paucity of studies on intracellular
infection of non-phagocytic cells by fungi [21]. The
majority of these studies have been carried out with
monocyte cell lines and macrophages [22–25]. Future
studies in this direction will benefit from the develop-
ment of new antibodies and other reagents that will
serve to examine the presence of fungal infections in
neurodegenerative diseases.
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